ArticleJournal of clinical oncology : official journal of the American Society of Clinical Oncology2023

First-Line Nivolumab Plus Ipilimumab in Recurrent/Metastatic Head and Neck Cancer-What Happened?

Barbara BurtnessPubMed ↗Publisher ↗

No numbers read from the abstract.